Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for PT Metro Healthcare Indonesia Tbk's Return-on-Tangible-Asset or its related term are showing as below:
ISX:CARE'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -6.42 Med: -1.8 Max: 4.97
Current: 0.84
During the past 10 years, PT Metro Healthcare Indonesia Tbk's highest Return-on-Tangible-Asset was 4.97%. The lowest was -6.42%. And the median was -1.80%.
ISX:CARE's Return-on-Tangible-Asset is ranked worse than 59.06% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 2.51
vs ISX:CARE: 0.84
PT Metro Healthcare Indonesia Tbk (ISX:CARE) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
PT Metro Healthcare Indonesia Tbk Return-on-Tangible-Asset Related Terms
PT Metro Healthcare Indonesia Tbk Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Metro Healthcare Indonesia Tbk Return-on-Tangible-Asset Chart
ISX:CARE vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, PT Metro Healthcare Indonesia Tbk's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Metro Healthcare Indonesia Tbk Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Metro Healthcare Indonesia Tbk's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where PT Metro Healthcare Indonesia Tbk's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 0.01% mean?
PT Metro Healthcare Indonesia Tbk (ISX:CARE) has a Return-on-Tangible-Asset of 0.01% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. According to the industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #401 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 59.1%.
Is PT Metro Healthcare Indonesia Tbk's Return-on-Tangible-Asset too high?
PT Metro Healthcare Indonesia Tbk's current Return-on-Tangible-Asset is 0.01%. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.51. PT Metro Healthcare Indonesia Tbk's value of 0.01% is 99.6% below this industry median. Based on the distribution chart, PT Metro Healthcare Indonesia Tbk ranks #401 out of 679 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Metro Healthcare Indonesia Tbk has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Metro Healthcare Indonesia Tbk's Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #401 out of 679 companies for Return-on-Tangible-Asset. This places PT Metro Healthcare Indonesia Tbk in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.51. PT Metro Healthcare Indonesia Tbk's value of 0.01% is 99.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.51, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Metro Healthcare Indonesia Tbk's current Return-on-Tangible-Asset of 0.01% is 99.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Metro Healthcare Indonesia Tbk's current Return-on-Tangible-Asset is 0.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Metro Healthcare Indonesia Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk (ISX:CARE) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp371.94, compared to a current price of Rp426.00 — trading 14.5% above its estimated fair value. The current Return-on-Tangible-Asset is 0.01% and 99.6% below the Healthcare Providers & Services industry median of 2.51. PT Metro Healthcare Indonesia Tbk's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For PT Metro Healthcare Indonesia Tbk (ISX:CARE), the current Return-on-Tangible-Asset is 0.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued.
The current stock price of Rp426.00 is trading 14.5% above its estimated GF Value™ of Rp371.94.
GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Modestly Overvalued.
Key valuation signals for ISX:CARE:
Return-on-Tangible-Asset: 0.01%
GF Value™: Rp371.94 vs. price of Rp426.00 (14.5% above fair value)
Industry Position: 99.6% below the Healthcare Providers & Services median (#401 of 679)
No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
71GF Score
Get the complete analysis for ISX:CARE
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:CARE has been successfully added to your 
